FDA NDC Directory · JSON-LD · Markdown

OPZELURA

NDC 50881-007 · HUMAN PRESCRIPTION DRUG · CREAM

Generic nameruxolitinib
Labeler / ManufacturerIncyte Corporation
Marketing categoryNew Drug Application (innovator) · App NDA215309
Dosage form / routeCREAM · TOPICAL
Active ingredientsRUXOLITINIB PHOSPHATE (15 mg/g)
Marketing started20210921
Package count4

External sources

Source: openFDA. Public-domain (CC0).